sitaxsentan: Clinical Trials

4 trials of sitaxsentan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1

Follow sitaxsentan: new trials by email Literature Review of sitaxsentan trials Research Report on sitaxsentan

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma
sitaxentan, placebo - Effect of Sitaxsentan on Airway Remodeling in Severe Asthma
Phase 2TerminatedInstitut National de la Santé Et de la Recherche Médicale, France172009-11-012012-05-10
Sitaxsentan in Proteinuric Chronic Kidney Disease
Sitaxsentan, Nifedipine, Placebo tablet - Chronic Kidney Disease, Proteinuria
Phase 2CompletedUniversity of Edinburgh272007-07-142025-02-07
Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects
Open, Nifedipine, Placebo - Chronic Kidney Disease
Phase 2CompletedPfizer272007-05-092023-07-06
Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery
sitaxsentan (Thelin), Placebo - Cardiac Surgery Subjects, Subjects Undergoing CABG and/or Cardiac Valve Replacement
Phase 2CompletedPfizer292006-08-102022-09-08

Conditions studied

Renal Insufficiency, Chronic (2)  ·  Airway Obstruction (1)  ·  Airway Remodeling (1)  ·  Asthma (1)  ·  Proteinuria (1)

Sponsors

Pfizer (2)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  University of Edinburgh (1)

Countries

United Kingdom (2)  ·  France (1)  ·  United States (1)

Top investigators

David Webb, MD DSc FRCP FRSE FMedSci (1)  ·  Neeraj Dhaun, MBChB (1)

Results publications

PMID 21357275, PMID 23243212, PMID 24890823, PMID 25801761, PMID 31177906